Fresenius says Akorn deal closure could take until next year
November 22, 2017 at 03:31 AM EST
FRANKFURT, Nov 22 (Reuters) - German healthcare group Fresenius SE said the planned takeover of Akorn , a U.S. maker of liquid generic drugs, might not be completed before next year as the U.S. antitrust review could take longer than expected.
